Mirum Pharmaceuticals, Inc. (MIRM)
USD 40.6
(-4.81%)
USD 40.6
(-4.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -70.94 Million | -120.13 Million | -132.75 Million | -89.07 Million | -39.36 Million | -373 Thousand |
| Net Income | -163.41 Million | -135.66 Million | -83.98 Million | -103.27 Million | -52.55 Million | -17.34 Million |
| Depreciation & Amortization | 10.82 Million | 3.68 Million | 975 Thousand | 623 Thousand | 324 Thousand | - |
| Deferred income taxes | 9.77 Million | -6.58 Million | 595 Thousand | 72 Thousand | - | - |
| Stock-based compensation | 35.02 Million | 27 Million | 23.08 Million | 12.55 Million | 6.07 Million | 51 Thousand |
| Change in working capital | -22.64 Million | -21.05 Million | 16.98 Million | 611 Thousand | 7.12 Million | 2.43 Million |
| Other non-cash items | 59.48 Million | 12.47 Million | -90.41 Million | 335 Thousand | -326 Thousand | 12.08 Million |
| Investing Cash Flow | -107.2 Million | 7.7 Million | 48.54 Million | 37.87 Million | -127.78 Million | -7.5 Million |
| Investments in PPE | -20.1 Million | -278 Thousand | -19.02 Million | -225 Thousand | -281 Thousand | -7.5 Million |
| Acquisitions | -212.76 Million | -7.97 Million | -19 Million | -38.09 Million | 127.5 Million | - |
| Investment purchases | -27.32 Million | -132.32 Million | -198.02 Million | -74.56 Million | -152 Million | - |
| Sales/Maturities of investments | 153 Million | 140.3 Million | 157.6 Million | 112.66 Million | 24.5 Million | - |
| Other Investing Activities | 105.67 Million | 7.97 Million | 127 Million | 38.09 Million | -127.5 Million | -11.25 Million |
| Financing Cash Flow | 336.6 Million | 109.08 Million | 73.46 Million | 181.28 Million | 127.17 Million | 59.83 Million |
| Debt repayment | -109.72 Million | -5.55 Million | -64.45 Million | -49.57 Million | - | -50 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 227.15 Million | 114.63 Million | 9.01 Million | 131.87 Million | 67.2 Million | 59.78 Million |
| Other Financing Activities | 219.17 Million | 109.08 Million | 128.9 Million | 98.99 Million | 59.97 Million | 89.75 Million |
| Accounts receivables | -43.97 Million | -20.72 Million | - | - | - | - |
| Accounts payables | 30.77 Million | 7.63 Million | 22.65 Million | 3.68 Million | 10.05 Million | 2.44 Million |
| Inventory | -4.39 Million | -3.44 Million | -495 Thousand | - | - | - |
| Other working capital | -5.05 Million | -4.51 Million | -5.17 Million | -3.07 Million | -2.93 Million | -12 Thousand |
| Cash at beginning of period | 28 Million | 131.34 Million | 142.08 Million | 11.97 Million | 51.96 Million | - |
| Cash at end of period | 286.32 Million | 128 Million | 131.34 Million | 142.08 Million | 11.97 Million | 51.96 Million |
| Capital Expenditure | -20.1 Million | -278 Thousand | -19.02 Million | -225 Thousand | -281 Thousand | -7.5 Million |
| Effect of forex changes on cash | -133 Thousand | 12 Thousand | -1000.00 | 29 Thousand | -27 Thousand | - |
| Net cash flow / Change in cash | 258.32 Million | -3.33 Million | -10.74 Million | 130.11 Million | -39.99 Million | 51.96 Million |
| Free Cash Flow | -91.05 Million | -120.41 Million | -151.78 Million | -89.3 Million | -39.64 Million | -7.87 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.63 Million | -25.27 Million | -163.41 Million | -33.14 Million | -23.58 Million | -74.03 Million |
| Depreciation & Amortization | 5.85 Million | 5.66 Million | 10.82 Million | 5.39 Million | 2.66 Million | 1.19 Million |
| Deferred income taxes | - | - | 9.77 Million | -30.31 Million | -638 Thousand | 32 Thousand |
| Stock-based compensation | 11.83 Million | 11.45 Million | 35.02 Million | 9.72 Million | 8.38 Million | 8.35 Million |
| Change in working capital | -794 Thousand | 21.73 Million | -22.64 Million | -10.86 Million | -5.64 Million | 11.5 Million |
| Other non-cash items | 29.41 Million | 932 Thousand | 59.48 Million | 42.58 Million | 601 Thousand | 50.62 Million |
| Investing Cash Flow | -72.71 Million | -13 Thousand | -107.2 Million | -2 Million | -182.76 Million | 35.54 Million |
| Investments in PPE | -10.77 Million | -13 Thousand | -20.1 Million | -5 Million | - | -15.06 Million |
| Acquisitions | - | - | -212.76 Million | 239.81 Million | -212.76 Million | 15 Million |
| Investment purchases | -61.93 Million | - | -27.32 Million | - | - | -4.88 Million |
| Sales/Maturities of investments | - | - | 153 Million | 3 Million | 30 Million | 55.5 Million |
| Other Investing Activities | -71.93 Million | - | 105.67 Million | -2 Million | 30 Million | -15 Million |
| Financing Cash Flow | 7.29 Million | 1.2 Million | 336.6 Million | 1.77 Million | 207.12 Million | 114.7 Million |
| Debt repayment | - | - | -109.72 Million | -115.49 Million | - | -112.61 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.29 Million | 1.2 Million | 227.15 Million | 2.05 Million | 202.36 Million | 2.09 Million |
| Other Financing Activities | 7.29 Million | 1.2 Million | 219.17 Million | -280.99 Thousand | 4.76 Million | 225.22 Million |
| Accounts receivables | -5.43 Million | 12.96 Million | -43.97 Million | -20.13 Million | -12.5 Million | -10.66 Million |
| Accounts payables | 6.94 Million | 11.27 Million | 30.77 Million | 12.52 Million | 10.28 Million | 24.17 Million |
| Inventory | -3.44 Million | -3.17 Million | -4.39 Million | -2.18 Million | -439 Thousand | -989 Thousand |
| Other working capital | 1.13 Million | 660 Thousand | -5.05 Million | -1.07 Million | -2.98 Million | -1.02 Million |
| Cash at beginning of period | 302.84 Million | 286.32 Million | 28 Million | 303.05 Million | 297.22 Million | 149.41 Million |
| Cash at end of period | 233.24 Million | 302.84 Million | 286.32 Million | 286.32 Million | 303.05 Million | 297.22 Million |
| Capital Expenditure | -10.77 Million | -13 Thousand | -20.1 Million | -5 Million | - | -15.06 Million |
| Effect of forex changes on cash | -119 Thousand | 113 Thousand | -133 Thousand | 108 Thousand | -315 Thousand | -114 Thousand |
| Net cash flow / Change in cash | -69.59 Million | 16.51 Million | 258.32 Million | -16.73 Million | 5.83 Million | 147.8 Million |
| Free Cash Flow | -14.58 Million | 15.19 Million | -91.05 Million | -21.61 Million | -18.22 Million | -17.39 Million |
VRNO
KLRFM
GUJPETR
BXRDF
HUMX
SAGA